Pedro Perdigão

Hoje, dia 29 de fevereiro, é o Dia Mundial das Doenças Raras. Para assinalar a data, investigadores do @cnc_uc vão estar no UC Exploratório para desmistificar Doenças Raras e dar a conhecer algum do trabalho realizado na área. noticias.uc.pt/artigos/o-que-…

🔍 Unveiling the Power of #ViralVectors in #Polyglutamine Disorders! 🧠 Our team's latest review @Brain1878 by @CarinaHenriqu explores the game-changing role of viral vectors in modeling polyglutamine disorders. 🧬🔗💉🐀🔬 👉doi.org/10.1093/brain/… @cnc_uc @UnivdeCoimbra

Join us at @Exploratório on #RareDiseaseDay to delve into the impact and aspirations for rare diseases, followed by a dance performance.💃 This initiative is part of the Less Rare project led by @som_catarina to bring awareness to rare diseases. 🙂 @cnc_uc @UnivdeCoimbra

Last day to apply!

🧬 Passionate about gene editing and intrigued by brain disorders? 🧠 Exciting news! We're offering a Research Fellowship for an MSc researcher keen on exploring cutting-edge CRISPR/Cas13 technologies to rescue Spinocerebellar Ataxia Type 3. Join our dynamic team @LAlmeidaLab!😉

Join us on our next #CInTech #mRNA webinar series, where Dr. @GiaccaMauro from @KingsCollegeLon and @UniTrieste will share latest advancements on mRNA-based therapies!🧬💡🚀 Tomorrow at 10 am (UTC) 👇 videoconf-colibri.zoom.us/j/91924996574 #mRNA #Therapeutics #WebinarSeries

🧬Delved into the intriguing world of synthetic DNA templates for mRNA production with Dr. Carmen Mañas from 4basebio at the #CInTech #mRNA webinar. An interesting approach for the production and scale-up of mRNA therapeutics in GMP-like conditions. 🏭 @cnc_uc @UnivdeCoimbra

Our next #CInTech #mRNA webinar will be presented by Dr. Carmen Mañas from 4basebio to talk about advances in synthetic DNA constructs for mRNA production! ⚒️🧬💉 🗓️Tomorrow! 11h30 👀#success" target="_blank" rel="nofollow noopener">videoconf-colibri.zoom.us/j/91269449812#… See you there! @cnc_uc @UnivdeCoimbra

🧬🔬🇧🇪 Back at the @ESGCT meeting in Brussels with our fantastic group, here with President Dr. @JuanBueren! Excitement is in the air as we dive into cutting-edge advances in gene and cell therapy. Let the knowledge exchange begin! #ESGCT2023 #GeneTherapy @cnc_uc @UnivdeCoimbra

Join the mRNA revolution! 💉🧬 We are starting a webinar series on #mRNA production and therapeutics, under the scope of #CInTech consortium supported by the 🇪🇺 More information coming soon!

📢 Exciting news! Our preprint study on isolation of EV-AAVs for brain gene delivery led by @CarinaHenriqu is online!🧠🧪 Stay tuned for the follow-up peer-reviewed version! 😉 #GeneDelivery #BrainHealth #Science #biotech @cnc_uc @uc_iii @UnivdeCoimbra

Thrilled to kick off our first day at the @ASGCTherapy meeting in Los Angeles! The energy is electrifying as we connect with experts and explore the frontiers of #genecelltherapy. Excited for the inspiring talks and looking forward to the incredible days ahead! #TeamLA @cnc_uc

Great experience at the @FENSorg regional meeting in our sunny Faro, Algarve! ☀️🌊 Our team shared our latest breakthroughs in #machadojoseph disease treatments and connected with other experts in the field. #FENS #neuroscience @cnc_uc @uc_iii @UnivdeCoimbra

Fascinating #PubhD talk by Rodrigo at the Liquidâmbar on his PhD research over the effect of #machadojoseph disease on the clock genes. Love the idea of academics presenting their work in a pub! 👨‍🔬🍻 #PhDLife @cnc_uc @uc_iii @UnivdeCoimbra

Gene therapy for AIPL1 associated Leber Congenital Amaurosis is well tolerated in four children, with no safety concerns to date and efficacy signs, first of a kind trial for a severe blinding diseases 🧬💉👁️@ARVOinfo #arvo2023 @UCLeye @UCL_Retina @MichelMichaelid

@DavidRufinoRam1 Well done! 👏👏

We made it 🎊🥳! Running a Marathon 🏃🏃: check ✅

Keep on running !🏃🏃🏼‍♀️ We came back to the #Europamarathon with a bigger team this year! We were proud to represent @cnc_uc and support #ataxia association APAHE. We'll keep the tradition and hope you join us next year! 😃 #ScienceTrailblazers #TeamGoals @uc_iii @UnivdeCoimbra